Sichuan, China

De Wei

This inventor holds 1 USPTO granted patent. Top assignee: Chengdu Huitai Biomedicine Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: De Wei. Retrieved from https://idiyas.com/inventor/de-wei-wwws3chq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: De Wei - Innovator in Biomedicine

Introduction

De Wei is a prominent inventor based in Sichuan, China. He has made significant contributions to the field of biomedicine, particularly in the development of therapeutic solutions for fibrosis diseases. His innovative work has garnered attention in the scientific community.

Latest Patents

De Wei holds a patent for a polypeptide, polypeptide fragment, and derivative thereof, along with their applications. This invention focuses on the preparation of drugs aimed at preventing and treating fibrosis diseases. His patent is a testament to his commitment to advancing medical science and improving patient outcomes. He has 1 patent to his name.

Career Highlights

De Wei is associated with Chengdu Huitai Biomedicine Co., Ltd., where he applies his expertise in biomedicine. His role at the company allows him to collaborate with other talented professionals in the field. His work is characterized by a dedication to innovation and a passion for improving healthcare solutions.

Collaborations

Some of his notable coworkers include Yi Ding and Ling Xiao. Together, they contribute to the research and development efforts at Chengdu Huitai Biomedicine Co., Ltd. Their collaborative efforts enhance the potential for groundbreaking discoveries in biomedicine.

Conclusion

De Wei's contributions to the field of biomedicine, particularly through his patent on polypeptides, highlight his role as an innovator. His work not only advances scientific knowledge but also holds promise for improving treatments for fibrosis diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…